Page last updated: 2024-09-04

cd 437 and arsenic

cd 437 has been researched along with arsenic in 1 studies

Compound Research Comparison

Studies (cd 437)	Trials (cd 437)	Recent Studies (post-2010) (cd 437)	Studies (arsenic)	Trials (arsenic)	Recent Studies (post-2010) (arsenic)
134	0	26	27,806	280	13,049

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
de Thé, H; Giannì, M	1

Other Studies

1 other study(ies) available for cd 437 and arsenic

Article	Year
In acute promyelocytic leukemia NB4 cells, the synthetic retinoid CD437 induces contemporaneously apoptosis, a caspase-3-mediated degradation of PML/RARalpha protein and the PML retargeting on PML-nuclear bodies. Leukemia, 1999, Volume: 13, Issue:5 Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Caspase 3; Caspases; Cell Line; Humans; Leukemia, Promyelocytic, Acute; Neoplasm Proteins; Nuclear Proteins; Oxides; Promyelocytic Leukemia Protein; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Retinoids; Transcription Factors; Tumor Suppressor Proteins	1999

Article

Year

In acute promyelocytic leukemia NB4 cells, the synthetic retinoid CD437 induces contemporaneously apoptosis, a caspase-3-mediated degradation of PML/RARalpha protein and the PML retargeting on PML-nuclear bodies.

Leukemia, 1999, Volume: 13, Issue:5

Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Caspase 3; Caspases; Cell Line; Humans; Leukemia, Promyelocytic, Acute; Neoplasm Proteins; Nuclear Proteins; Oxides; Promyelocytic Leukemia Protein; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Retinoids; Transcription Factors; Tumor Suppressor Proteins

1999